chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1wk post vax reddened raised warm, itching area noted @ approx site of inj;
Initial unsolicited report received from a consumer 11 December 2015. This case involves a female patient (age was not reported) who was vaccinated with a dose of INFLUENZA VACCINE (Flu Vaccine) (manufacturer: unknown,batch number, dose, dose in series, route and site of administration was not reported) and with a dose of PREVNAR 13 (Manufactured by: Pfizer; batch number, dose, dose in series, route and site of administration was not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, the patient's arm got sore for more than one day and a half. Laboratory data and corrective treatment was not reported. On an unknown date, the patient was recovered from the event. Follow-up information received from a consumer on 07 January 2016. No new information reported. List of documents held by sender: none.
No adverse events related to vaccination.  However, had breakthrough covid episode two months later.  Symptoms included cough, sore throat, headaches, body aches, extreme fatigue, brain fog
Moderna on 4/23 and 5/21. Positive on 9/4 admitted 9/8 to current
According to mother, hives developed 3 hours after vaccination.  Hives worsened the next day.  Patients mother called to report symptoms on 7/13/16.  Mother was advised to take child to urgent care.
4 days after vaccine, diarrhea began.  It has persisted for 8 days now.
Pt received vaccine around 1020 am by 1030 am- he had profuse vomiting, cough, wheezing and low O2 Sat. Pt was given BENADRYL and Albuterol w/O2. He developed facial swelling and hives around the eyes. Pt was sent to ER for further management.
This initial spontaneous case, was received from other health professional (nurse) on 06-Nov-2017, concerning a patient of unspecified gender and age. This case refers to 11th out of 18 reports. The patient's medical history and concomitant medications were not reported. It was reported that most of the patients received the vaccine on 09-Oct-2017 (as reported), the patient was administered with FLUVIRIN (dose, route of administration, anatomical location, batch number, expiry date: not reported) (explicitly coded to expired vaccine used). It was reported that, the patient had no reaction/had not experienced any adverse event after vaccination. The reporter assessed the events as non-serious.
vesicular rash started 13 days after Varicella vaccine given no fever or other symptoms
Began with rash on legs. More than 50 papules on thighs, lower abdomen and arms. Calamine lotions and Atarax for itching.
pins & needles sensation and "twitching" in muscles of bilateral lower extremeties, chest discomfort, abdominal pain, headache
patient reported of dizziness 5 minutes after the Pfzer Covid vaccine, dose 1.  Patient was recommended  to drink some water while she was still sitting on the chair in the vaccine room with her dad.  After about 15 minutes , patient reported that she felt and back to normal .. She then left with her dad.
Developed papulo-macular rash all over body including scalp scattered after vaccination with PEDIARIX, HIB, PCV, and PO ROTATEQ. Rx: Tylenol and Benadryl cream 2 x.
very tired; Light headed/Light headedness; Feel nauseous; headache; This spontaneous case was reported by a pharmacist and describes the occurrence of DIZZINESS (Light headed/Light headedness), NAUSEA (Feel nauseous), FATIGUE (very tired) and HEADACHE (headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (patient reported allergic to macrolides.) and Hashimoto's disease in 2000. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 01-Jan-2000 to an unknown date for an unknown indication.    On 08-Jan-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced HEADACHE (headache). On 08-Jan-2021 at 2:15 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Light headed/Light headedness) and NAUSEA (Feel nauseous). On 08-Jan-2021 at 8:00 PM, the patient experienced FATIGUE (very tired). On 10-Jan-2021, DIZZINESS (Light headed/Light headedness) and NAUSEA (Feel nauseous) had resolved. On 18-Jan-2021, FATIGUE (very tired) had resolved. At the time of the report, HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Influenza: negative (Negative) Patient tested negative for Influenza.. In 2021, SARS-CoV-2 antibody test: not evident (Negative) Not evident. In 2021, SARS-CoV-2 test: negative (Negative) Patient tested negative for COVID-19.     mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reported Negative to CSV Test.   No treatment medication is provided.   This case was linked to MOD-2021-218938 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 13-Jun-2021: Follow-up received and reporter information updated, patient information updated, vaccine information updated, event information and outcomes updated.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Severe Migraine, Vomiting, Muscle Pain, Nausea, Fatigue that lead to a chronic Cough and Cold which inhibits ability to work comfortably and inability to sleep  properly for weeks.
Mom states pt recvd immun & w/in 15 min pt began crying devel into screaming by 1130AM began jerking movements this continued until 3PM; pt seen by MD who felt rxn was passing;
Probably around February 2021, I have noticed the difficulty in breathing. Any kind of exertion started to get worse and worse. I cannot really pinpoint. It is just a continually gradual worsening. It was something that was not really that noticeable yet. It is far more memorable in the last 6 or 8 months. As it got worse and worse, I decided to seek help, around 3 months ago. Over those 3 months I have been going for several test. Then I am going to be sent to a pulmonologist. I was being stubborn, and I should have been keeping track of it. I had no idea that I had a need to. I can barely go 10 to 15 normal steps at a normal pace, and I am out of breath. The doctors cannot figure out what or why I am having difficulty catching my breath.
COUGH, FEVER, MALAISE Narrative:  TEMPERATURE 101.2; SYMPTOMS LASTED APPROX 36 HRS; EMPLOYEE MISSED 1 DAY OF WORK  Other Relevant History:
This is a spontaneous report obtained from a contactable pharmacist through a Pfizer sales representative. A patient of an unspecified age, gender, race and ethnicity received, on an unknown date, PREVNAR 13 at single dose and quadrivalent influenza vaccine (QIV), both for immunization. Relevant medical history and concomitant medications were unknown. On 03Aug2016, the patient's hand was swelling and rainbow color to skin. BACTRIM was given as treatment by physician. Clinical outcome of the events was unknown at time of this report.
Cluster of 6-10 hive-like bumps on right shoulder/back. Bumps were itchy, some were fluid filled. Bumps eventually scabbed over after 4-5 days. Bumps have gotten smaller and have mostly resolved after 10 days but some still persist and are still itchy. Bumps seemed to cluster around a tattoo in the same area ? also in same area that bra strap met the band of bra.
The patient is a 62y.o. female with PMHx of angioedema, asthma, COPD on 2L home O2, DMII, diverticulitis, dyslipidemia, FSGS, hypertension and OSA on cpap who presents to the ED with c/o shortness of breath. Patient states that she has been experiencing increasing shortness of breath over the last 2 weeks and over the last 2 days felt like she couldn't get a breath in. C/o subjective fever, chills, generalized body aches and congestion. Patient states she has been vaccinated, per registry patient received one dose Pfizer Covid-19 Vaccine on 4/13/2021, no other doses documented. Upon examination, patient states that she is feeling terrible, however states she is feeling a little better than when she presented to ED. Denies any dizziness, lightheadedness, chest pain, palpitations, abdominal pain, nausea, vomiting, diarrhea or constipation. Denies ETOH, marijuana or illicit drug use.
Swollen lymph?s in left arm pit.  Still have after 4 days from when I first noticed it. Very uncomfortable. I am not near my medical doctor(I am currently out-of- state), so have not seen anyone about this.
15FEB PM started vomiting,irritability,crying had episode of throwing arms & head back,then acting sleepy;17FEB adm d/t persistent vomiting,irritability,lethargy,exam  red throat;20FEB lt internal strabimus;23FEB 6th nerve palsy;
Headache, small temperature (up approx. 2 degrees) and fatigue. Minimal acetaminophen taken and extra sleep. Headache began 1.5 days after vaccine and lasted for approx. 1.5 days.  Elevated temperature was noticed on night of the second day and gone by morning. Headache for 1.5-2 . Must note: this could easily be springtime allergies at work.
12 hours after vaccination I noticed the lymph node on my right clavicle, the same side as the injection,  was enlarged.  The same lymph node had become enlarged after the 1st Dose of Moderna and it had returned to its normal size before the 2nd Dose.  24 to 36 hours after the 2nd Dose Moderna, the lymph node had grown almost to the size of a golf ball. Today, 06/11/2021, the lymph node has not returned to its normal size. It is now the size of a pea.  Four days after the vaccination I had tachycardia. It returned to normal after a couple of days.
Sore throat, body aches, fatigue, cough, nasal/sinus congestion, fever-100. Some symptoms are still continuing today 11/6/09.
Information has been received from a health professional concerning herself, who, on an unspecified date, was vaccinated IM with a 0.5mL dose of GARDASIL vaccine (yeast). Subsequently, shortly after the vaccination the patient experienced swollen lymph nodes in her legs. A biopsy was performed of the swollen lymph nodes, and the result was negative. At the time of the report, the patient had not recovered. No product quality complaint was involved. This is one of two reports from the same source. Additional information has been requested.
This spontaneous report was received from a physician and refers to two patients of unknown age and gender. The patients' medical history, concurrent conditions, concomitant medications, and drug reactions or allergies were not provided. On 09-FEB-2019, the patients were vaccinated with improperly stored doses of LIQUID PEDVAXHIB intramuscularly from lot # R005114 with expiration date 26-NOV-2020, (strength and anatomical location were not reported) for prophylaxis. The vaccine was exposed to a temperature of 73 degrees Fahrenheit for a time frame of 74 hours and 45 minutes. There was no previous temperature excursion. No adverse effects were reported. No product quality complaint (PQC) was involved. The call was due to a data logger. This case was considered non-valid due to lack of patient identifiers. Upon receipt of follow-up information, it was determined that this case is now valid because patient identifier was received. Follow-up information was received from the physician on 25-FEB-2019. The physician has provided the patient's initials. The physician also stated that she was advised previously that it was ok to use the vaccine which was exposed to the temperature excursion. This is one of the two reports received from the same reporter.
he got Covid-19 2months after his 2nd PBCV purple cap formula shot; he got Covid-19 2months after his 2nd PBCV purple cap formula shot; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "he got Covid-19 2months after his 2nd PBCV purple cap formula shot". The patient underwent the following laboratory tests and procedures: covid-19: positive.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Cellulitis of injected arm Narrative:  Resolved after 5 days abx tx. No further reaction noted.
Received influenza vaccine on 10/14/15. Started feeling pins and needles sensation systemically starting from legs and throughout extremities and face the morning of 10/24/15. Symptoms have not improved or resolved.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with VARIVAX lot # L004653 with ex. 11-FEB-2017, (dose and route were not provided). No adverse effects were reported. Additional information has been requested.
got sick; Initial information received on 25-Nov-2020 regarding an unsolicited valid non-serious case from a patient.  This case involves a patient of unknown age who experienced got sick (illness), while the patient received vaccine influenza vaccine.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medication was not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (lot number and expiration date not reported) via unknown route in unknown administration site for prophylaxis vaccination.   On an unknown date, (latency unknown) after the administration of suspect vaccine therapy, the patient got sick (illness) everytime and so now patient did not take it.   No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome was unknown for the event.     There will be no information available on the batch number for this case.
having constant headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (having constant headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032b21a and 026a21a) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-May-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (having constant headache). At the time of the report, HEADACHE (having constant headache) had not resolved.            No Concomitant medications were reported  Patient had several studies done to them with nothing found to be wrong with them. They got CT scan and MRI done. No Treatment information was reported.
This spontaneous report as received from a licensed practical nurse refers to a 62 year old female patient. On 19-SEP-2014, the patient was vaccinated with a dose of PREVNAR (dose, route, lot # and expiration date were not provided) instead of PNEUMOVAX 23 which was the intended vaccine. The licensed practical nurse did not clarify how or why the error occurred, whether it was medication confusion or healthcare provider error. She reported that this patient did not experience any adverse effects. It was unknown if the patient sought medical attention. At the time of the report, the patient's
On 21 June 2000, 21 July 2000, and 15 December 2000, the vaccinee received the first, second, and third doses of Engerix-B (routes and sites not specified). Subsequently, the vaccinee was found to be a nonresponder. As of 27 March 2001, the outcome of the event was unknown.
Redness/erythema; It does get itchy from time to time; broke out with no itching; red pimples on chest, neck, stomach (above belly button), arms (little); This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness/erythema) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008B21A and 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Mar-2021 at 1:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021 at 1:15 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced DERMATITIS ACNEIFORM (red pimples on chest, neck, stomach (above belly button), arms (little)) and RASH (broke out with no itching). On an unknown date, the patient experienced ERYTHEMA (Redness/erythema) (seriousness criterion hospitalization) and PRURITUS (It does get itchy from time to time). The patient was hospitalized from 09-Apr-2021 to 22-Apr-2021 due to ERYTHEMA. The patient was treated with CLINDAMYCIN ongoing from 10-Apr-2021 for Acne, at a dose of 1 percent twice a day. At the time of the report, ERYTHEMA (Redness/erythema), DERMATITIS ACNEIFORM (red pimples on chest, neck, stomach (above belly button), arms (little)) and PRURITUS (It does get itchy from time to time) had not resolved and RASH (broke out with no itching) outcome was unknown.            Concomitant product use was not provided by the reporter.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Outcome of event changed to not recovered. Event erythema and seriousness criterion (hospitalization) was added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Contracted COVID - 19 requiring hospitalization for SOB, several months after receiving second dose of vaccine
On 09/01/2021 a Moderna vial was opened at approximately 05:30 PM, at closing of the business day (7pm) the Moderna vial was not removed from the refrigerator and discarded.  Subsequently the vial was used the next day on 09/02/2021 at 12:22 PM to vaccinate the patient approximately  7 hours past its 12 hour refrigerated expiration. The Moderna vial was always kept refrigerated.
Herpes zoster in varicella vaccine recipient (unclear if patient received one or two doses in the past).
27FEB91 mom noticed child fussy & felt warm (not hot) temp not measured; Had rash (bumpy) on chest, face & head, eyes puffy; 6MAR91 TC mom said sx lasted 24hrs & then was fine;
On 5/15/21 I woke up with muscle pain and fatigue.  By 11 am I started with chills and fever.  Throughout the day I took Tylenol and then Ibprophen.  I used Ice packs to try to lower my temperature but throughout the day it continued to rise.  By 7 pm I was just over 104.  I took a very cold shower to reduce the fever.    FYI I had COVID in Nov 2020.  My first vaccine on 3/17/2021 produced a fever of 102 and was controlled with Ibprophen.  The second vaccine was considerably worse and not controlled by pain relievers.
pt was exposed to chickenpox @ daycare & exp a fever; fever to 103 & a rash;dx roseola;
I was exposed to COVID-19 on 01/09/2022. I started having symptoms on 01/10/2022 and I continued to work. I had a fever, chills and body aches. I was taking a lot of preventative supplements at that time and did not receive a prescription. I previously tested positive for COVID-19 on 08/04/2022 and on 11/07/2022. After my November COVID-19 infection, I have elevated liver enzymes since having COVID-19. As of today, my liver enzymes have improved but are not in normal range.
Teen arrived in office at 3:16pm to receive HPV#2. Temp 98.8 & teen denied any reaction after first vaccine. Vaccine given & when checking out, child started to feel faint, dizzy, difficulty hearing & seeing. Initial vitals taken at approx. 3:35pm in the waiting room as teen was sitting down. Teen then walked w/assistance to lay down. At this time, teen admitted to feeling faint on the ride home after receiving first vaccine in May. Teen cont'd to c/o difficulty seeing "everything going light & dark" & unable to hear well. CRNP, RN, LPN and Dr in exam room. Child cont'd to feel dizzy, difficulty hearing & seeing and BP elevated 30 min after onset of symptoms. Last BP 156/100, teen alert & oriented but slow to respond, starting off into space & pale. EMS called at 3:57pm. Report called to ER. EMS arrived at 4:06pm. Teen taken to medical center via EMS.
fussiness evening of immun followed by fever of 103, Tuesday-fever, Wednesday pt had convuls;
18 hours after receiving second shot of the Moderna vaccine (received at about 6:45 pm on Monday 03/29/2021) I started to have uncontrollable shaking, chills, throughout my body which lasted over an hour, after that I felt like I had the flu with aches and weakness along with extreme fatigue for the next 48 hours before I felt more normal. I also had very noticeable aching light pain from one shoulder over to the other shoulder around the back of my neck during the first 6 hours of when this started. Today (4/1/2021) I woke up feeling normal and stronger and not so fatigue. I have been taking medications for diagnosed heart failure and do not know if the interactions of these helped to bring this on. My first shot of the Moderna vaccine shot was just a sore arm where the shot was given with no other reaction and I was on the heart failure medications back then.
12hrs after vaccine: loss of taste x 24hrs, night sweats x4nights, mild chest/throat tightness
After the second shot, she felt sleepy for a 3 days. This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (After the second shot, she felt sleepy for a 3 days.) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (Seasonal Migraine on & off triggered by Florescent light and changes in weather. not under medication.).   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SOMNOLENCE (After the second shot, she felt sleepy for a 3 days.). On 30-Apr-2021, SOMNOLENCE (After the second shot, she felt sleepy for a 3 days.) had resolved.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-530707, MOD-2022-530742 (Patient Link).
Case number PHEH2014YS020445, is an initial spontaneous report from a pharmacist received on 08 OCT 2014. This report refers to a 53-year-old male patient. Past medical history and concomitant medications were not reported. He was inadvertently vaccinated with FLUVIRIN 2014/2015 (batch number: 1413401) subcutaneously on 07 OCT 2014. No adverse event was reported following this medication error (inappropriate route of vaccination).
ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE HYPERCAPNIC RESPIRATORY FAILURE CHRONIC RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA